Journal of Cancer Sciences

Review Article

Artificial Intelligence in Radiation Oncology: Applications and Future Direction

Wang T1,3, Goel HL1-3, Ding L1, Bradford C1, Khalifeh A1, Liu F1, Fan Y1, Kuo I-L1, Larosa S1, Yancey J1, Jones G1, Harris D1, Bishop-Jodoin M1, Smith K1, Iandoli M1, Laurie F1, Goel S2 and FitzGerald TJ1*

1Department of Radiation Oncology, University of Massachusetts Chan Medical School, Worcester, MA, USA
2Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA
3Co-first Authors
*Address for Correspondence:Thomas J FitzGerald, Department of Radiation Oncology, University of Massachusetts Chan Medical School, Worcester, MA, USA E-mail Id: TJ.FitzGerald@umassmemorial.org
Submission:28 February, 2024 Accepted:27 March, 2024 Published:02 April, 2024
Copyright:© 2024 Wang T, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The practice of radiation oncology is changing at a rapid pace. As models of care and department reimbursement change, departments are evaluating an increasing number of patients with complex medical backgrounds which must be acknowledged as increasing difficult treatment plans are developed. With altered fractionation strategies, compressed fractionation treatment delivery, and highly sophisticated radiation therapy treatment technology, radiation therapy has evolved into a highly rigorous discipline applying multiple overlapping image datasets to define targets of interest with sophisticated image guidance tools to ensure accuracy of therapy. Integrated with biomarkers associated with treatment response and therapeutic resistance, radiation therapy can be delivered to tumor with altered doses to image-guided subsets of disease. The datasets now required to generate radiation oncology treatment plans are becoming increasingly large and complex. Ultimately, artificial intelligence models will mature to ensure accuracy and consistency to department workflows and therapeutic decisions including contouring and treatment planning. Artificial intelligence can and will be applied to all elements of daily patient care as well as clinical translational research. In this paper, we explore how multiple components of artificial intelligence will support the radiation oncology work force and therapy-guided clinical trials moving forward.